BRCA2 and neoplasm: To examine the impact of BRCA2 R2971Q variant on tumor predisposition, we generated a cohort of Brca2RQ/+, Brca2RQ/RQ and Brca2RQ/KO animals and monitored their tumor-free survival for 750 days.